W Bradford Smith
CIK 1317678 · See remarks · last filed 2026-05-15
W Bradford Smith is a corporate insider who has filed 28 SEC Form 4 insider transactions across 4 companies since 2007. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
28
-$1.27M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYRA | Director | — | $0.70 | — | $0 | 5 | 2025-05-16 |
| Q32 Bio Inc. (FIXX) Delisted | See remarks | 14,219 | $16.82 | $239.2K | -$1.27M | 17 | 2023-02-27 |
| OCUL | CFO and Treasurer | — | $8.94 | — | $0 | 3 | 2017-02-10 |
| NeuroMetrix, Inc. (NURO) Delisted | Chief Financial Officer | — | $4.58 | — | $0 | 2 | 2008-04-03 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-15 | — | Disp (D) | −640 | $0 | |
| 2025-05-16 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2023-07-05 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2023-02-27 | Q32 Bio Inc. (FIXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-11 | Q32 Bio Inc. (FIXX) Delisted | Sell (S) | −3,729 | -$5.2K | EDGAR |
| 2023-01-04 | Q32 Bio Inc. (FIXX) Delisted | Exer (M) | +13,530 | $0 | EDGAR |
| 2022-06-21 | LYRA | Grant (A) | — | $0 | EDGAR |
| 2022-02-28 | Q32 Bio Inc. (FIXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-12 | Q32 Bio Inc. (FIXX) Delisted | Mixed | +4,418 | -$8.2K | EDGAR |